Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| SAVA | Cassava Sciences, Inc. | 0.00% | 45.88 | 0.0% | $167.43m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -0.04% | 27.07 | 14.1% | $159.28m | |
| ICLR | ICON plc | 0.00% | 266.39 | 2.8% | $142.73m | |
| CTLT | Catalent, Inc. | -0.05% | 108.19 | 2.0% | $117.41m | |
| BHC | Bausch Health Cos., Inc. | -0.04% | 27.07 | 0.0% | $112.90m | |
| HZNP | Horizon Therapeutics Plc | 0.00% | 91.10 | 5.4% | $106.55m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.00% | 144.30 | 2.1% | $88.31m | |
| UTHR | United Therapeutics Corp. | 0.00% | 213.96 | 13.9% | $83.03m | |
| ARGX | argenx SE | 0.00% | 291.50 | 0.0% | $68.34m | |
| PRGO | Perrigo Co. Plc | 0.03% | 39.74 | 6.9% | $50.64m | |
| BRBR | BellRing Brands, Inc. | 0.04% | 25.93 | 0.0% | $28.46m | |
| PCRX | Pacira Biosciences, Inc. | 0.00% | 64.08 | 9.8% | $26.06m | |
| CORT | Corcept Therapeutics, Inc. | 0.00% | 18.45 | 5.5% | $21.72m | |
| SAGE | SAGE Therapeutics, Inc. | 0.00% | 42.93 | 7.6% | $19.98m | |
| IRWD | Ironwood Pharmaceuticals, Inc. | 0.00% | 11.72 | 9.5% | $19.47m |
Company Profile
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.